Global Circulating Tumor Cells Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Circulating Tumor Cells market size is predicted to grow from US$ 2652 million in 2025 to US$ 8391 million in 2031; it is expected to grow at a CAGR of 21.2% from 2025 to 2031.
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
Global Circulating Tumor Cells main players are Menarini-Silicon Biosystems, Qiagen?Adnagen?, Clearbridge Biomedics, Celsee, Fluidigm. Global top five manufacturers hold a share over 30%.
LPI (LP Information)' newest research report, the “Circulating Tumor Cells Industry Forecast” looks at past sales and reviews total world Circulating Tumor Cells sales in 2024, providing a comprehensive analysis by region and market sector of projected Circulating Tumor Cells sales for 2025 through 2031. With Circulating Tumor Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Circulating Tumor Cells industry.
This Insight Report provides a comprehensive analysis of the global Circulating Tumor Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Circulating Tumor Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Circulating Tumor Cells market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Circulating Tumor Cells and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Circulating Tumor Cells.
This report presents a comprehensive overview, market shares, and growth opportunities of Circulating Tumor Cells market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Circulating Tumor Cells market size is predicted to grow from US$ 2652 million in 2025 to US$ 8391 million in 2031; it is expected to grow at a CAGR of 21.2% from 2025 to 2031.
Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
Global Circulating Tumor Cells main players are Menarini-Silicon Biosystems, Qiagen?Adnagen?, Clearbridge Biomedics, Celsee, Fluidigm. Global top five manufacturers hold a share over 30%.
LPI (LP Information)' newest research report, the “Circulating Tumor Cells Industry Forecast” looks at past sales and reviews total world Circulating Tumor Cells sales in 2024, providing a comprehensive analysis by region and market sector of projected Circulating Tumor Cells sales for 2025 through 2031. With Circulating Tumor Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Circulating Tumor Cells industry.
This Insight Report provides a comprehensive analysis of the global Circulating Tumor Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Circulating Tumor Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Circulating Tumor Cells market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Circulating Tumor Cells and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Circulating Tumor Cells.
This report presents a comprehensive overview, market shares, and growth opportunities of Circulating Tumor Cells market by product type, application, key players and key regions and countries.
Segmentation by Type:
- CTC Enrichment
- CTC Detection
- CTC Analysis
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Lung Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Menarini-Silicon Biosystems
- Qiagen (Adnagen)
- Advanced Cell Diagnostics
- ApoCell
- Epic Sciences
- Greiner Bio-one GmbH
- Cynvenio
- SurExamBio-Tech
- Fluxion Biosciences
- Ikonisys
- Hangzhou Watson Biotech
- Biocept
- CytoTrack
- Guangzhou Wondfo Biotech
- Celsee
- Clearbridge Biomedics
- ANGLE plc
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Circulating Tumor Cells Market Size (2020-2031)
2.1.2 Circulating Tumor Cells Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Circulating Tumor Cells by Country/Region (2020, 2024 & 2031)
2.2 Circulating Tumor Cells Segment by Type
2.2.1 CTC Enrichment
2.2.2 CTC Detection
2.2.3 CTC Analysis
2.3 Circulating Tumor Cells Market Size by Type
2.3.1 Circulating Tumor Cells Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Circulating Tumor Cells Market Size Market Share by Type (2020-2025)
2.4 Circulating Tumor Cells Segment by Application
2.4.1 Breast Cancer
2.4.2 Prostate Cancer
2.4.3 Colorectal Cancer
2.4.4 Lung Cancer
2.4.5 Others
2.5 Circulating Tumor Cells Market Size by Application
2.5.1 Circulating Tumor Cells Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Circulating Tumor Cells Market Size Market Share by Application (2020-2025)
3 CIRCULATING TUMOR CELLS MARKET SIZE BY PLAYER
3.1 Circulating Tumor Cells Market Size Market Share by Player
3.1.1 Global Circulating Tumor Cells Revenue by Player (2020-2025)
3.1.2 Global Circulating Tumor Cells Revenue Market Share by Player (2020-2025)
3.2 Global Circulating Tumor Cells Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CIRCULATING TUMOR CELLS BY REGION
4.1 Circulating Tumor Cells Market Size by Region (2020-2025)
4.2 Global Circulating Tumor Cells Annual Revenue by Country/Region (2020-2025)
4.3 Americas Circulating Tumor Cells Market Size Growth (2020-2025)
4.4 APAC Circulating Tumor Cells Market Size Growth (2020-2025)
4.5 Europe Circulating Tumor Cells Market Size Growth (2020-2025)
4.6 Middle East & Africa Circulating Tumor Cells Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Circulating Tumor Cells Market Size by Country (2020-2025)
5.2 Americas Circulating Tumor Cells Market Size by Type (2020-2025)
5.3 Americas Circulating Tumor Cells Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Circulating Tumor Cells Market Size by Region (2020-2025)
6.2 APAC Circulating Tumor Cells Market Size by Type (2020-2025)
6.3 APAC Circulating Tumor Cells Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Circulating Tumor Cells Market Size by Country (2020-2025)
7.2 Europe Circulating Tumor Cells Market Size by Type (2020-2025)
7.3 Europe Circulating Tumor Cells Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Circulating Tumor Cells by Region (2020-2025)
8.2 Middle East & Africa Circulating Tumor Cells Market Size by Type (2020-2025)
8.3 Middle East & Africa Circulating Tumor Cells Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CIRCULATING TUMOR CELLS MARKET FORECAST
10.1 Global Circulating Tumor Cells Forecast by Region (2026-2031)
10.1.1 Global Circulating Tumor Cells Forecast by Region (2026-2031)
10.1.2 Americas Circulating Tumor Cells Forecast
10.1.3 APAC Circulating Tumor Cells Forecast
10.1.4 Europe Circulating Tumor Cells Forecast
10.1.5 Middle East & Africa Circulating Tumor Cells Forecast
10.2 Americas Circulating Tumor Cells Forecast by Country (2026-2031)
10.2.1 United States Market Circulating Tumor Cells Forecast
10.2.2 Canada Market Circulating Tumor Cells Forecast
10.2.3 Mexico Market Circulating Tumor Cells Forecast
10.2.4 Brazil Market Circulating Tumor Cells Forecast
10.3 APAC Circulating Tumor Cells Forecast by Region (2026-2031)
10.3.1 China Circulating Tumor Cells Market Forecast
10.3.2 Japan Market Circulating Tumor Cells Forecast
10.3.3 Korea Market Circulating Tumor Cells Forecast
10.3.4 Southeast Asia Market Circulating Tumor Cells Forecast
10.3.5 India Market Circulating Tumor Cells Forecast
10.3.6 Australia Market Circulating Tumor Cells Forecast
10.4 Europe Circulating Tumor Cells Forecast by Country (2026-2031)
10.4.1 Germany Market Circulating Tumor Cells Forecast
10.4.2 France Market Circulating Tumor Cells Forecast
10.4.3 UK Market Circulating Tumor Cells Forecast
10.4.4 Italy Market Circulating Tumor Cells Forecast
10.4.5 Russia Market Circulating Tumor Cells Forecast
10.5 Middle East & Africa Circulating Tumor Cells Forecast by Region (2026-2031)
10.5.1 Egypt Market Circulating Tumor Cells Forecast
10.5.2 South Africa Market Circulating Tumor Cells Forecast
10.5.3 Israel Market Circulating Tumor Cells Forecast
10.5.4 Turkey Market Circulating Tumor Cells Forecast
10.6 Global Circulating Tumor Cells Forecast by Type (2026-2031)
10.7 Global Circulating Tumor Cells Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Circulating Tumor Cells Forecast
11 KEY PLAYERS ANALYSIS
11.1 Menarini-Silicon Biosystems
11.1.1 Menarini-Silicon Biosystems Company Information
11.1.2 Menarini-Silicon Biosystems Circulating Tumor Cells Product Offered
11.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Menarini-Silicon Biosystems Main Business Overview
11.1.5 Menarini-Silicon Biosystems Latest Developments
11.2 Qiagen (Adnagen)
11.2.1 Qiagen (Adnagen) Company Information
11.2.2 Qiagen (Adnagen) Circulating Tumor Cells Product Offered
11.2.3 Qiagen (Adnagen) Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Qiagen (Adnagen) Main Business Overview
11.2.5 Qiagen (Adnagen) Latest Developments
11.3 Advanced Cell Diagnostics
11.3.1 Advanced Cell Diagnostics Company Information
11.3.2 Advanced Cell Diagnostics Circulating Tumor Cells Product Offered
11.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Advanced Cell Diagnostics Main Business Overview
11.3.5 Advanced Cell Diagnostics Latest Developments
11.4 ApoCell
11.4.1 ApoCell Company Information
11.4.2 ApoCell Circulating Tumor Cells Product Offered
11.4.3 ApoCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 ApoCell Main Business Overview
11.4.5 ApoCell Latest Developments
11.5 Epic Sciences
11.5.1 Epic Sciences Company Information
11.5.2 Epic Sciences Circulating Tumor Cells Product Offered
11.5.3 Epic Sciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Epic Sciences Main Business Overview
11.5.5 Epic Sciences Latest Developments
11.6 Greiner Bio-one GmbH
11.6.1 Greiner Bio-one GmbH Company Information
11.6.2 Greiner Bio-one GmbH Circulating Tumor Cells Product Offered
11.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Greiner Bio-one GmbH Main Business Overview
11.6.5 Greiner Bio-one GmbH Latest Developments
11.7 Cynvenio
11.7.1 Cynvenio Company Information
11.7.2 Cynvenio Circulating Tumor Cells Product Offered
11.7.3 Cynvenio Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Cynvenio Main Business Overview
11.7.5 Cynvenio Latest Developments
11.8 SurExamBio-Tech
11.8.1 SurExamBio-Tech Company Information
11.8.2 SurExamBio-Tech Circulating Tumor Cells Product Offered
11.8.3 SurExamBio-Tech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 SurExamBio-Tech Main Business Overview
11.8.5 SurExamBio-Tech Latest Developments
11.9 Fluxion Biosciences
11.9.1 Fluxion Biosciences Company Information
11.9.2 Fluxion Biosciences Circulating Tumor Cells Product Offered
11.9.3 Fluxion Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Fluxion Biosciences Main Business Overview
11.9.5 Fluxion Biosciences Latest Developments
11.10 Ikonisys
11.10.1 Ikonisys Company Information
11.10.2 Ikonisys Circulating Tumor Cells Product Offered
11.10.3 Ikonisys Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Ikonisys Main Business Overview
11.10.5 Ikonisys Latest Developments
11.11 Hangzhou Watson Biotech
11.11.1 Hangzhou Watson Biotech Company Information
11.11.2 Hangzhou Watson Biotech Circulating Tumor Cells Product Offered
11.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Hangzhou Watson Biotech Main Business Overview
11.11.5 Hangzhou Watson Biotech Latest Developments
11.12 Biocept
11.12.1 Biocept Company Information
11.12.2 Biocept Circulating Tumor Cells Product Offered
11.12.3 Biocept Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Biocept Main Business Overview
11.12.5 Biocept Latest Developments
11.13 CytoTrack
11.13.1 CytoTrack Company Information
11.13.2 CytoTrack Circulating Tumor Cells Product Offered
11.13.3 CytoTrack Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 CytoTrack Main Business Overview
11.13.5 CytoTrack Latest Developments
11.14 Guangzhou Wondfo Biotech
11.14.1 Guangzhou Wondfo Biotech Company Information
11.14.2 Guangzhou Wondfo Biotech Circulating Tumor Cells Product Offered
11.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Guangzhou Wondfo Biotech Main Business Overview
11.14.5 Guangzhou Wondfo Biotech Latest Developments
11.15 Celsee
11.15.1 Celsee Company Information
11.15.2 Celsee Circulating Tumor Cells Product Offered
11.15.3 Celsee Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Celsee Main Business Overview
11.15.5 Celsee Latest Developments
11.16 Clearbridge Biomedics
11.16.1 Clearbridge Biomedics Company Information
11.16.2 Clearbridge Biomedics Circulating Tumor Cells Product Offered
11.16.3 Clearbridge Biomedics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Clearbridge Biomedics Main Business Overview
11.16.5 Clearbridge Biomedics Latest Developments
11.17 ANGLE plc
11.17.1 ANGLE plc Company Information
11.17.2 ANGLE plc Circulating Tumor Cells Product Offered
11.17.3 ANGLE plc Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 ANGLE plc Main Business Overview
11.17.5 ANGLE plc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Circulating Tumor Cells Market Size (2020-2031)
2.1.2 Circulating Tumor Cells Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Circulating Tumor Cells by Country/Region (2020, 2024 & 2031)
2.2 Circulating Tumor Cells Segment by Type
2.2.1 CTC Enrichment
2.2.2 CTC Detection
2.2.3 CTC Analysis
2.3 Circulating Tumor Cells Market Size by Type
2.3.1 Circulating Tumor Cells Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Circulating Tumor Cells Market Size Market Share by Type (2020-2025)
2.4 Circulating Tumor Cells Segment by Application
2.4.1 Breast Cancer
2.4.2 Prostate Cancer
2.4.3 Colorectal Cancer
2.4.4 Lung Cancer
2.4.5 Others
2.5 Circulating Tumor Cells Market Size by Application
2.5.1 Circulating Tumor Cells Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Circulating Tumor Cells Market Size Market Share by Application (2020-2025)
3 CIRCULATING TUMOR CELLS MARKET SIZE BY PLAYER
3.1 Circulating Tumor Cells Market Size Market Share by Player
3.1.1 Global Circulating Tumor Cells Revenue by Player (2020-2025)
3.1.2 Global Circulating Tumor Cells Revenue Market Share by Player (2020-2025)
3.2 Global Circulating Tumor Cells Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CIRCULATING TUMOR CELLS BY REGION
4.1 Circulating Tumor Cells Market Size by Region (2020-2025)
4.2 Global Circulating Tumor Cells Annual Revenue by Country/Region (2020-2025)
4.3 Americas Circulating Tumor Cells Market Size Growth (2020-2025)
4.4 APAC Circulating Tumor Cells Market Size Growth (2020-2025)
4.5 Europe Circulating Tumor Cells Market Size Growth (2020-2025)
4.6 Middle East & Africa Circulating Tumor Cells Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Circulating Tumor Cells Market Size by Country (2020-2025)
5.2 Americas Circulating Tumor Cells Market Size by Type (2020-2025)
5.3 Americas Circulating Tumor Cells Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Circulating Tumor Cells Market Size by Region (2020-2025)
6.2 APAC Circulating Tumor Cells Market Size by Type (2020-2025)
6.3 APAC Circulating Tumor Cells Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Circulating Tumor Cells Market Size by Country (2020-2025)
7.2 Europe Circulating Tumor Cells Market Size by Type (2020-2025)
7.3 Europe Circulating Tumor Cells Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Circulating Tumor Cells by Region (2020-2025)
8.2 Middle East & Africa Circulating Tumor Cells Market Size by Type (2020-2025)
8.3 Middle East & Africa Circulating Tumor Cells Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CIRCULATING TUMOR CELLS MARKET FORECAST
10.1 Global Circulating Tumor Cells Forecast by Region (2026-2031)
10.1.1 Global Circulating Tumor Cells Forecast by Region (2026-2031)
10.1.2 Americas Circulating Tumor Cells Forecast
10.1.3 APAC Circulating Tumor Cells Forecast
10.1.4 Europe Circulating Tumor Cells Forecast
10.1.5 Middle East & Africa Circulating Tumor Cells Forecast
10.2 Americas Circulating Tumor Cells Forecast by Country (2026-2031)
10.2.1 United States Market Circulating Tumor Cells Forecast
10.2.2 Canada Market Circulating Tumor Cells Forecast
10.2.3 Mexico Market Circulating Tumor Cells Forecast
10.2.4 Brazil Market Circulating Tumor Cells Forecast
10.3 APAC Circulating Tumor Cells Forecast by Region (2026-2031)
10.3.1 China Circulating Tumor Cells Market Forecast
10.3.2 Japan Market Circulating Tumor Cells Forecast
10.3.3 Korea Market Circulating Tumor Cells Forecast
10.3.4 Southeast Asia Market Circulating Tumor Cells Forecast
10.3.5 India Market Circulating Tumor Cells Forecast
10.3.6 Australia Market Circulating Tumor Cells Forecast
10.4 Europe Circulating Tumor Cells Forecast by Country (2026-2031)
10.4.1 Germany Market Circulating Tumor Cells Forecast
10.4.2 France Market Circulating Tumor Cells Forecast
10.4.3 UK Market Circulating Tumor Cells Forecast
10.4.4 Italy Market Circulating Tumor Cells Forecast
10.4.5 Russia Market Circulating Tumor Cells Forecast
10.5 Middle East & Africa Circulating Tumor Cells Forecast by Region (2026-2031)
10.5.1 Egypt Market Circulating Tumor Cells Forecast
10.5.2 South Africa Market Circulating Tumor Cells Forecast
10.5.3 Israel Market Circulating Tumor Cells Forecast
10.5.4 Turkey Market Circulating Tumor Cells Forecast
10.6 Global Circulating Tumor Cells Forecast by Type (2026-2031)
10.7 Global Circulating Tumor Cells Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Circulating Tumor Cells Forecast
11 KEY PLAYERS ANALYSIS
11.1 Menarini-Silicon Biosystems
11.1.1 Menarini-Silicon Biosystems Company Information
11.1.2 Menarini-Silicon Biosystems Circulating Tumor Cells Product Offered
11.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Menarini-Silicon Biosystems Main Business Overview
11.1.5 Menarini-Silicon Biosystems Latest Developments
11.2 Qiagen (Adnagen)
11.2.1 Qiagen (Adnagen) Company Information
11.2.2 Qiagen (Adnagen) Circulating Tumor Cells Product Offered
11.2.3 Qiagen (Adnagen) Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Qiagen (Adnagen) Main Business Overview
11.2.5 Qiagen (Adnagen) Latest Developments
11.3 Advanced Cell Diagnostics
11.3.1 Advanced Cell Diagnostics Company Information
11.3.2 Advanced Cell Diagnostics Circulating Tumor Cells Product Offered
11.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Advanced Cell Diagnostics Main Business Overview
11.3.5 Advanced Cell Diagnostics Latest Developments
11.4 ApoCell
11.4.1 ApoCell Company Information
11.4.2 ApoCell Circulating Tumor Cells Product Offered
11.4.3 ApoCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 ApoCell Main Business Overview
11.4.5 ApoCell Latest Developments
11.5 Epic Sciences
11.5.1 Epic Sciences Company Information
11.5.2 Epic Sciences Circulating Tumor Cells Product Offered
11.5.3 Epic Sciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Epic Sciences Main Business Overview
11.5.5 Epic Sciences Latest Developments
11.6 Greiner Bio-one GmbH
11.6.1 Greiner Bio-one GmbH Company Information
11.6.2 Greiner Bio-one GmbH Circulating Tumor Cells Product Offered
11.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Greiner Bio-one GmbH Main Business Overview
11.6.5 Greiner Bio-one GmbH Latest Developments
11.7 Cynvenio
11.7.1 Cynvenio Company Information
11.7.2 Cynvenio Circulating Tumor Cells Product Offered
11.7.3 Cynvenio Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Cynvenio Main Business Overview
11.7.5 Cynvenio Latest Developments
11.8 SurExamBio-Tech
11.8.1 SurExamBio-Tech Company Information
11.8.2 SurExamBio-Tech Circulating Tumor Cells Product Offered
11.8.3 SurExamBio-Tech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 SurExamBio-Tech Main Business Overview
11.8.5 SurExamBio-Tech Latest Developments
11.9 Fluxion Biosciences
11.9.1 Fluxion Biosciences Company Information
11.9.2 Fluxion Biosciences Circulating Tumor Cells Product Offered
11.9.3 Fluxion Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Fluxion Biosciences Main Business Overview
11.9.5 Fluxion Biosciences Latest Developments
11.10 Ikonisys
11.10.1 Ikonisys Company Information
11.10.2 Ikonisys Circulating Tumor Cells Product Offered
11.10.3 Ikonisys Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Ikonisys Main Business Overview
11.10.5 Ikonisys Latest Developments
11.11 Hangzhou Watson Biotech
11.11.1 Hangzhou Watson Biotech Company Information
11.11.2 Hangzhou Watson Biotech Circulating Tumor Cells Product Offered
11.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Hangzhou Watson Biotech Main Business Overview
11.11.5 Hangzhou Watson Biotech Latest Developments
11.12 Biocept
11.12.1 Biocept Company Information
11.12.2 Biocept Circulating Tumor Cells Product Offered
11.12.3 Biocept Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Biocept Main Business Overview
11.12.5 Biocept Latest Developments
11.13 CytoTrack
11.13.1 CytoTrack Company Information
11.13.2 CytoTrack Circulating Tumor Cells Product Offered
11.13.3 CytoTrack Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 CytoTrack Main Business Overview
11.13.5 CytoTrack Latest Developments
11.14 Guangzhou Wondfo Biotech
11.14.1 Guangzhou Wondfo Biotech Company Information
11.14.2 Guangzhou Wondfo Biotech Circulating Tumor Cells Product Offered
11.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Guangzhou Wondfo Biotech Main Business Overview
11.14.5 Guangzhou Wondfo Biotech Latest Developments
11.15 Celsee
11.15.1 Celsee Company Information
11.15.2 Celsee Circulating Tumor Cells Product Offered
11.15.3 Celsee Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Celsee Main Business Overview
11.15.5 Celsee Latest Developments
11.16 Clearbridge Biomedics
11.16.1 Clearbridge Biomedics Company Information
11.16.2 Clearbridge Biomedics Circulating Tumor Cells Product Offered
11.16.3 Clearbridge Biomedics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Clearbridge Biomedics Main Business Overview
11.16.5 Clearbridge Biomedics Latest Developments
11.17 ANGLE plc
11.17.1 ANGLE plc Company Information
11.17.2 ANGLE plc Circulating Tumor Cells Product Offered
11.17.3 ANGLE plc Circulating Tumor Cells Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 ANGLE plc Main Business Overview
11.17.5 ANGLE plc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Circulating Tumor Cells Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Circulating Tumor Cells Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of CTC Enrichment
Table 4. Major Players of CTC Detection
Table 5. Major Players of CTC Analysis
Table 6. Circulating Tumor Cells Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Circulating Tumor Cells Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Circulating Tumor Cells Market Size Market Share by Type (2020-2025)
Table 9. Circulating Tumor Cells Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Circulating Tumor Cells Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Circulating Tumor Cells Market Size Market Share by Application (2020-2025)
Table 12. Global Circulating Tumor Cells Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Circulating Tumor Cells Revenue Market Share by Player (2020-2025)
Table 14. Circulating Tumor Cells Key Players Head office and Products Offered
Table 15. Circulating Tumor Cells Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Circulating Tumor Cells Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Circulating Tumor Cells Market Size Market Share by Region (2020-2025)
Table 20. Global Circulating Tumor Cells Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Circulating Tumor Cells Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Circulating Tumor Cells Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Circulating Tumor Cells Market Size Market Share by Country (2020-2025)
Table 24. Americas Circulating Tumor Cells Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Circulating Tumor Cells Market Size Market Share by Type (2020-2025)
Table 26. Americas Circulating Tumor Cells Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Circulating Tumor Cells Market Size Market Share by Application (2020-2025)
Table 28. APAC Circulating Tumor Cells Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Circulating Tumor Cells Market Size Market Share by Region (2020-2025)
Table 30. APAC Circulating Tumor Cells Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Circulating Tumor Cells Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Circulating Tumor Cells Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Circulating Tumor Cells Market Size Market Share by Country (2020-2025)
Table 34. Europe Circulating Tumor Cells Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Circulating Tumor Cells Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Circulating Tumor Cells Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Circulating Tumor Cells Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Circulating Tumor Cells Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Circulating Tumor Cells
Table 40. Key Market Challenges & Risks of Circulating Tumor Cells
Table 41. Key Industry Trends of Circulating Tumor Cells
Table 42. Global Circulating Tumor Cells Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Circulating Tumor Cells Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Circulating Tumor Cells Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Circulating Tumor Cells Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Menarini-Silicon Biosystems Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 47. Menarini-Silicon Biosystems Circulating Tumor Cells Product Offered
Table 48. Menarini-Silicon Biosystems Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Menarini-Silicon Biosystems Main Business
Table 50. Menarini-Silicon Biosystems Latest Developments
Table 51. Qiagen (Adnagen) Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 52. Qiagen (Adnagen) Circulating Tumor Cells Product Offered
Table 53. Qiagen (Adnagen) Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Qiagen (Adnagen) Main Business
Table 55. Qiagen (Adnagen) Latest Developments
Table 56. Advanced Cell Diagnostics Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 57. Advanced Cell Diagnostics Circulating Tumor Cells Product Offered
Table 58. Advanced Cell Diagnostics Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Advanced Cell Diagnostics Main Business
Table 60. Advanced Cell Diagnostics Latest Developments
Table 61. ApoCell Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 62. ApoCell Circulating Tumor Cells Product Offered
Table 63. ApoCell Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. ApoCell Main Business
Table 65. ApoCell Latest Developments
Table 66. Epic Sciences Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 67. Epic Sciences Circulating Tumor Cells Product Offered
Table 68. Epic Sciences Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Epic Sciences Main Business
Table 70. Epic Sciences Latest Developments
Table 71. Greiner Bio-one GmbH Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 72. Greiner Bio-one GmbH Circulating Tumor Cells Product Offered
Table 73. Greiner Bio-one GmbH Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Greiner Bio-one GmbH Main Business
Table 75. Greiner Bio-one GmbH Latest Developments
Table 76. Cynvenio Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 77. Cynvenio Circulating Tumor Cells Product Offered
Table 78. Cynvenio Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Cynvenio Main Business
Table 80. Cynvenio Latest Developments
Table 81. SurExamBio-Tech Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 82. SurExamBio-Tech Circulating Tumor Cells Product Offered
Table 83. SurExamBio-Tech Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. SurExamBio-Tech Main Business
Table 85. SurExamBio-Tech Latest Developments
Table 86. Fluxion Biosciences Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 87. Fluxion Biosciences Circulating Tumor Cells Product Offered
Table 88. Fluxion Biosciences Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Fluxion Biosciences Main Business
Table 90. Fluxion Biosciences Latest Developments
Table 91. Ikonisys Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 92. Ikonisys Circulating Tumor Cells Product Offered
Table 93. Ikonisys Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Ikonisys Main Business
Table 95. Ikonisys Latest Developments
Table 96. Hangzhou Watson Biotech Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 97. Hangzhou Watson Biotech Circulating Tumor Cells Product Offered
Table 98. Hangzhou Watson Biotech Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Hangzhou Watson Biotech Main Business
Table 100. Hangzhou Watson Biotech Latest Developments
Table 101. Biocept Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 102. Biocept Circulating Tumor Cells Product Offered
Table 103. Biocept Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Biocept Main Business
Table 105. Biocept Latest Developments
Table 106. CytoTrack Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 107. CytoTrack Circulating Tumor Cells Product Offered
Table 108. CytoTrack Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. CytoTrack Main Business
Table 110. CytoTrack Latest Developments
Table 111. Guangzhou Wondfo Biotech Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 112. Guangzhou Wondfo Biotech Circulating Tumor Cells Product Offered
Table 113. Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Guangzhou Wondfo Biotech Main Business
Table 115. Guangzhou Wondfo Biotech Latest Developments
Table 116. Celsee Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 117. Celsee Circulating Tumor Cells Product Offered
Table 118. Celsee Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Celsee Main Business
Table 120. Celsee Latest Developments
Table 121. Clearbridge Biomedics Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 122. Clearbridge Biomedics Circulating Tumor Cells Product Offered
Table 123. Clearbridge Biomedics Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. Clearbridge Biomedics Main Business
Table 125. Clearbridge Biomedics Latest Developments
Table 126. ANGLE plc Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 127. ANGLE plc Circulating Tumor Cells Product Offered
Table 128. ANGLE plc Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. ANGLE plc Main Business
Table 130. ANGLE plc Latest Developments
Table 1. Circulating Tumor Cells Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Circulating Tumor Cells Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of CTC Enrichment
Table 4. Major Players of CTC Detection
Table 5. Major Players of CTC Analysis
Table 6. Circulating Tumor Cells Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Circulating Tumor Cells Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Circulating Tumor Cells Market Size Market Share by Type (2020-2025)
Table 9. Circulating Tumor Cells Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Circulating Tumor Cells Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Circulating Tumor Cells Market Size Market Share by Application (2020-2025)
Table 12. Global Circulating Tumor Cells Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Circulating Tumor Cells Revenue Market Share by Player (2020-2025)
Table 14. Circulating Tumor Cells Key Players Head office and Products Offered
Table 15. Circulating Tumor Cells Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Circulating Tumor Cells Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Circulating Tumor Cells Market Size Market Share by Region (2020-2025)
Table 20. Global Circulating Tumor Cells Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Circulating Tumor Cells Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Circulating Tumor Cells Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Circulating Tumor Cells Market Size Market Share by Country (2020-2025)
Table 24. Americas Circulating Tumor Cells Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Circulating Tumor Cells Market Size Market Share by Type (2020-2025)
Table 26. Americas Circulating Tumor Cells Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Circulating Tumor Cells Market Size Market Share by Application (2020-2025)
Table 28. APAC Circulating Tumor Cells Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Circulating Tumor Cells Market Size Market Share by Region (2020-2025)
Table 30. APAC Circulating Tumor Cells Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Circulating Tumor Cells Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Circulating Tumor Cells Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Circulating Tumor Cells Market Size Market Share by Country (2020-2025)
Table 34. Europe Circulating Tumor Cells Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Circulating Tumor Cells Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Circulating Tumor Cells Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Circulating Tumor Cells Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Circulating Tumor Cells Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Circulating Tumor Cells
Table 40. Key Market Challenges & Risks of Circulating Tumor Cells
Table 41. Key Industry Trends of Circulating Tumor Cells
Table 42. Global Circulating Tumor Cells Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Circulating Tumor Cells Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Circulating Tumor Cells Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Circulating Tumor Cells Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Menarini-Silicon Biosystems Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 47. Menarini-Silicon Biosystems Circulating Tumor Cells Product Offered
Table 48. Menarini-Silicon Biosystems Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Menarini-Silicon Biosystems Main Business
Table 50. Menarini-Silicon Biosystems Latest Developments
Table 51. Qiagen (Adnagen) Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 52. Qiagen (Adnagen) Circulating Tumor Cells Product Offered
Table 53. Qiagen (Adnagen) Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Qiagen (Adnagen) Main Business
Table 55. Qiagen (Adnagen) Latest Developments
Table 56. Advanced Cell Diagnostics Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 57. Advanced Cell Diagnostics Circulating Tumor Cells Product Offered
Table 58. Advanced Cell Diagnostics Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Advanced Cell Diagnostics Main Business
Table 60. Advanced Cell Diagnostics Latest Developments
Table 61. ApoCell Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 62. ApoCell Circulating Tumor Cells Product Offered
Table 63. ApoCell Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. ApoCell Main Business
Table 65. ApoCell Latest Developments
Table 66. Epic Sciences Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 67. Epic Sciences Circulating Tumor Cells Product Offered
Table 68. Epic Sciences Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Epic Sciences Main Business
Table 70. Epic Sciences Latest Developments
Table 71. Greiner Bio-one GmbH Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 72. Greiner Bio-one GmbH Circulating Tumor Cells Product Offered
Table 73. Greiner Bio-one GmbH Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Greiner Bio-one GmbH Main Business
Table 75. Greiner Bio-one GmbH Latest Developments
Table 76. Cynvenio Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 77. Cynvenio Circulating Tumor Cells Product Offered
Table 78. Cynvenio Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Cynvenio Main Business
Table 80. Cynvenio Latest Developments
Table 81. SurExamBio-Tech Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 82. SurExamBio-Tech Circulating Tumor Cells Product Offered
Table 83. SurExamBio-Tech Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. SurExamBio-Tech Main Business
Table 85. SurExamBio-Tech Latest Developments
Table 86. Fluxion Biosciences Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 87. Fluxion Biosciences Circulating Tumor Cells Product Offered
Table 88. Fluxion Biosciences Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Fluxion Biosciences Main Business
Table 90. Fluxion Biosciences Latest Developments
Table 91. Ikonisys Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 92. Ikonisys Circulating Tumor Cells Product Offered
Table 93. Ikonisys Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Ikonisys Main Business
Table 95. Ikonisys Latest Developments
Table 96. Hangzhou Watson Biotech Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 97. Hangzhou Watson Biotech Circulating Tumor Cells Product Offered
Table 98. Hangzhou Watson Biotech Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Hangzhou Watson Biotech Main Business
Table 100. Hangzhou Watson Biotech Latest Developments
Table 101. Biocept Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 102. Biocept Circulating Tumor Cells Product Offered
Table 103. Biocept Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. Biocept Main Business
Table 105. Biocept Latest Developments
Table 106. CytoTrack Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 107. CytoTrack Circulating Tumor Cells Product Offered
Table 108. CytoTrack Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. CytoTrack Main Business
Table 110. CytoTrack Latest Developments
Table 111. Guangzhou Wondfo Biotech Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 112. Guangzhou Wondfo Biotech Circulating Tumor Cells Product Offered
Table 113. Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Guangzhou Wondfo Biotech Main Business
Table 115. Guangzhou Wondfo Biotech Latest Developments
Table 116. Celsee Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 117. Celsee Circulating Tumor Cells Product Offered
Table 118. Celsee Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Celsee Main Business
Table 120. Celsee Latest Developments
Table 121. Clearbridge Biomedics Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 122. Clearbridge Biomedics Circulating Tumor Cells Product Offered
Table 123. Clearbridge Biomedics Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. Clearbridge Biomedics Main Business
Table 125. Clearbridge Biomedics Latest Developments
Table 126. ANGLE plc Details, Company Type, Circulating Tumor Cells Area Served and Its Competitors
Table 127. ANGLE plc Circulating Tumor Cells Product Offered
Table 128. ANGLE plc Circulating Tumor Cells Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. ANGLE plc Main Business
Table 130. ANGLE plc Latest Developments
LIST OF FIGURES
Figure 1. Circulating Tumor Cells Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Circulating Tumor Cells Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Circulating Tumor Cells Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Circulating Tumor Cells Sales Market Share by Country/Region (2024)
Figure 8. Circulating Tumor Cells Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Circulating Tumor Cells Market Size Market Share by Type in 2024
Figure 10. Circulating Tumor Cells in Breast Cancer
Figure 11. Global Circulating Tumor Cells Market: Breast Cancer (2020-2025) & ($ millions)
Figure 12. Circulating Tumor Cells in Prostate Cancer
Figure 13. Global Circulating Tumor Cells Market: Prostate Cancer (2020-2025) & ($ millions)
Figure 14. Circulating Tumor Cells in Colorectal Cancer
Figure 15. Global Circulating Tumor Cells Market: Colorectal Cancer (2020-2025) & ($ millions)
Figure 16. Circulating Tumor Cells in Lung Cancer
Figure 17. Global Circulating Tumor Cells Market: Lung Cancer (2020-2025) & ($ millions)
Figure 18. Circulating Tumor Cells in Others
Figure 19. Global Circulating Tumor Cells Market: Others (2020-2025) & ($ millions)
Figure 20. Global Circulating Tumor Cells Market Size Market Share by Application in 2024
Figure 21. Global Circulating Tumor Cells Revenue Market Share by Player in 2024
Figure 22. Global Circulating Tumor Cells Market Size Market Share by Region (2020-2025)
Figure 23. Americas Circulating Tumor Cells Market Size 2020-2025 ($ millions)
Figure 24. APAC Circulating Tumor Cells Market Size 2020-2025 ($ millions)
Figure 25. Europe Circulating Tumor Cells Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Circulating Tumor Cells Market Size 2020-2025 ($ millions)
Figure 27. Americas Circulating Tumor Cells Value Market Share by Country in 2024
Figure 28. United States Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Circulating Tumor Cells Market Size Market Share by Region in 2024
Figure 33. APAC Circulating Tumor Cells Market Size Market Share by Type (2020-2025)
Figure 34. APAC Circulating Tumor Cells Market Size Market Share by Application (2020-2025)
Figure 35. China Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 39. India Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Circulating Tumor Cells Market Size Market Share by Country in 2024
Figure 42. Europe Circulating Tumor Cells Market Size Market Share by Type (2020-2025)
Figure 43. Europe Circulating Tumor Cells Market Size Market Share by Application (2020-2025)
Figure 44. Germany Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 45. France Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Circulating Tumor Cells Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Circulating Tumor Cells Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Circulating Tumor Cells Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 58. APAC Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 59. Europe Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 61. United States Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 62. Canada Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 63. Mexico Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 64. Brazil Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 65. China Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 66. Japan Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 67. Korea Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 69. India Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 70. Australia Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 71. Germany Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 72. France Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 73. UK Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 74. Italy Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 75. Russia Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 76. Egypt Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 77. South Africa Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 78. Israel Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 79. Turkey Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 80. Global Circulating Tumor Cells Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Circulating Tumor Cells Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 1. Circulating Tumor Cells Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Circulating Tumor Cells Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Circulating Tumor Cells Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Circulating Tumor Cells Sales Market Share by Country/Region (2024)
Figure 8. Circulating Tumor Cells Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Circulating Tumor Cells Market Size Market Share by Type in 2024
Figure 10. Circulating Tumor Cells in Breast Cancer
Figure 11. Global Circulating Tumor Cells Market: Breast Cancer (2020-2025) & ($ millions)
Figure 12. Circulating Tumor Cells in Prostate Cancer
Figure 13. Global Circulating Tumor Cells Market: Prostate Cancer (2020-2025) & ($ millions)
Figure 14. Circulating Tumor Cells in Colorectal Cancer
Figure 15. Global Circulating Tumor Cells Market: Colorectal Cancer (2020-2025) & ($ millions)
Figure 16. Circulating Tumor Cells in Lung Cancer
Figure 17. Global Circulating Tumor Cells Market: Lung Cancer (2020-2025) & ($ millions)
Figure 18. Circulating Tumor Cells in Others
Figure 19. Global Circulating Tumor Cells Market: Others (2020-2025) & ($ millions)
Figure 20. Global Circulating Tumor Cells Market Size Market Share by Application in 2024
Figure 21. Global Circulating Tumor Cells Revenue Market Share by Player in 2024
Figure 22. Global Circulating Tumor Cells Market Size Market Share by Region (2020-2025)
Figure 23. Americas Circulating Tumor Cells Market Size 2020-2025 ($ millions)
Figure 24. APAC Circulating Tumor Cells Market Size 2020-2025 ($ millions)
Figure 25. Europe Circulating Tumor Cells Market Size 2020-2025 ($ millions)
Figure 26. Middle East & Africa Circulating Tumor Cells Market Size 2020-2025 ($ millions)
Figure 27. Americas Circulating Tumor Cells Value Market Share by Country in 2024
Figure 28. United States Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 29. Canada Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 30. Mexico Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 31. Brazil Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 32. APAC Circulating Tumor Cells Market Size Market Share by Region in 2024
Figure 33. APAC Circulating Tumor Cells Market Size Market Share by Type (2020-2025)
Figure 34. APAC Circulating Tumor Cells Market Size Market Share by Application (2020-2025)
Figure 35. China Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 36. Japan Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 37. South Korea Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 38. Southeast Asia Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 39. India Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 40. Australia Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 41. Europe Circulating Tumor Cells Market Size Market Share by Country in 2024
Figure 42. Europe Circulating Tumor Cells Market Size Market Share by Type (2020-2025)
Figure 43. Europe Circulating Tumor Cells Market Size Market Share by Application (2020-2025)
Figure 44. Germany Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 45. France Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 46. UK Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 47. Italy Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 48. Russia Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 49. Middle East & Africa Circulating Tumor Cells Market Size Market Share by Region (2020-2025)
Figure 50. Middle East & Africa Circulating Tumor Cells Market Size Market Share by Type (2020-2025)
Figure 51. Middle East & Africa Circulating Tumor Cells Market Size Market Share by Application (2020-2025)
Figure 52. Egypt Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 53. South Africa Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 54. Israel Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 55. Turkey Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 56. GCC Countries Circulating Tumor Cells Market Size Growth 2020-2025 ($ millions)
Figure 57. Americas Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 58. APAC Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 59. Europe Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 60. Middle East & Africa Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 61. United States Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 62. Canada Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 63. Mexico Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 64. Brazil Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 65. China Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 66. Japan Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 67. Korea Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 68. Southeast Asia Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 69. India Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 70. Australia Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 71. Germany Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 72. France Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 73. UK Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 74. Italy Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 75. Russia Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 76. Egypt Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 77. South Africa Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 78. Israel Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 79. Turkey Circulating Tumor Cells Market Size 2026-2031 ($ millions)
Figure 80. Global Circulating Tumor Cells Market Size Market Share Forecast by Type (2026-2031)
Figure 81. Global Circulating Tumor Cells Market Size Market Share Forecast by Application (2026-2031)
Figure 82. GCC Countries Circulating Tumor Cells Market Size 2026-2031 ($ millions)
